Sean Godbout
Fortuna: 263 032 $ al 31/05/2026
Fortuna: 263 032 $ al 31/05/2026
Sean Godbout is currently the Chief Executive Officer at Conforma Therapeutics Corp.
Mr. Godbout is also the Chief Accounting Officer, VP & Global Controller at Biogen, Inc., a position starting in 2025.
Mr. Godbout completed undergraduate studies at Cornell University.
Mr. Godbout completed graduate studies and earned an MBA at Northeastern University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BIOGEN INC. 0 % | 01/04/2026 | 1.342 ( 0 % ) | 263 032 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOGEN INC. | Comptroller/Controller/Auditor | 01/01/2007 |
Conforma Therapeutics Corp.
Conforma Therapeutics Corp. BiotechnologyHealth Technology Designs and develops drugs for treatment of cancer | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Conforma Therapeutics Corp.
Conforma Therapeutics Corp. BiotechnologyHealth Technology Designs and develops drugs for treatment of cancer | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.